From NuGOwiki
The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB
| Taxonomy Navigation Box; search by |
|
All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein |
| Hypoxanthine | |
|---|---|
| Chemical Name | 3,7-dihydropurin-6-one |
| Chemical Formula | C5H4N4O |
| CAS Number | 68-94-0 |
| Chemical Information | HMDB00157 |
| Biochemical Taxonomy |
|
| Functional Taxonomy | Not Available |
| Nutritional Taxonomy | Not Available |
| Metabolic Pathways |
|
| Biofluid Location |
|
| Tissue Location |
|
| Normal Biofluid Concentrations |
|
| Normal Tissue Concentrations | Not Available |
| Diseases / Conditions Related to Nutrition |
|
| Other (Monogenic Disorders) |
|
| Abnormal Biofluid Concentrations |
|
| Abnormal Tissue Concentrations | Not Available |
| Physiological Processes | Not Available |
| Authors: | |
| Affiliations: |
Contents |
Introduction
guidelines
A naturally occurring purine derivative and a reaction intermediate in the metabolism of adenosine and in the formation of nucleic acids by the salvage pathway. Hypoxanthine is also a spontaneous deamination product of adenine.
Lesch-Nyhan disease is caused by deficiency of the purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase. (OMIN 308000).
Biological Function
Catabolism
guidelines
Hypoxanthine is a purine base generated from degradation of adenine and guanine nucleotides. Xanthine can be generated from hypoxanthine by oxidation.
Diseases / Conditions Related to Nutrition
- Degenerative disc disease
- Lung Cancer
- Non-compensated hydrocephalics (pre-shunt implanted)
- Patients with Canavan disease
- Patients with Lesch-Nyhan syndrome
- Self-compensated hydrocephalics
Other (Monogenic) Disorders
- Molybdenum cofactor deficiency OMIM: 252150
Nutritional Information
Drivers for biological variation
guidelines
Shaham O et al. observed decreased concentrations of hypoxanthine and xanthine upon a glucose challenge test Pubmed. Their explanation was that the decrease in hypoxanthine and xanthine may be explained by a combination of attenuated release and accelerated uptake. Hypoxanthine taken up by tissues can support nucleotide biosynthesis through the purine salvage pathway and may also be indicative of a switch from catabolism to anabolism of nucleic acids, analogues to the simultaneous transitions in fat and protein metabolism.